Related Experiment Video
Updated: Jun 10, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Hypertensive nephropathy: prevention and treatment recommendations
Peter D Hart1, George L Bakris
1Cook County (Stroger) Hospital, Division of Nephrology, Department of Medicine, Chicago, IL 60612, USA.
Aggressively lowering blood pressure with multiple agents, including renin-angiotensin-aldosterone (RAAS) blockers, is crucial for slowing chronic kidney disease (CKD) progression in hypertensive nephropathy patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) is a global epidemic, with hypertensive nephropathy being a major contributor.
- High morbidity, mortality, and costs associated with end-stage renal disease (ESRD) necessitate urgent therapeutic advancements.
- Effective management requires reducing albuminuria, controlling blood pressure, and slowing disease progression.
Purpose of the Study:
- To review the pathophysiology of hypertensive nephropathy.
- To present evidence supporting albuminuria reduction and specific blood pressure (BP) goals for slowing CKD progression.
- To outline strategies for preventing and optimally treating hypertensive nephropathy.
Main Methods:
- Discussion of hypertensive nephropathy pathophysiology.
- Review of current research on albuminuria reduction and BP targets.
- Analysis of evidence for therapeutic strategies.
Main Results:
- Albuminuria reduction is a key factor in slowing CKD progression.
- A blood pressure (BP) goal of <130 mmHg is recommended.
- Multiple agents, including RAAS blockers, are vital for treatment.
Conclusions:
- Hypertensive proteinuric nephropathy demands aggressive BP reduction.
- Combination therapy including RAAS blockers, calcium antagonists, and diuretics is essential.
- This approach maximally slows progression to ESRD.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction